Ariel Effrigan

So I had just recently finished my first startup and then I was doing some... Well, what does that mean?

Yeah.

So that company I built for about three and a half years.

And then part of those assets we absorbed into this company, but mainly the operations we closed down because of COVID.

And then I had a bunch of opportunities.

That company was relatively successful.

And because of that, yeah, I had a lot of great opportunities.

Just in terms of the clients, the impact on patients, as well as being revenue.

So we built that startup completely bootstrapped.

So that was a very exciting journey.

And what got me really excited about MDI was the interest that they had, the specific problem that they're solving within healthcare.

as well as the team is pretty incredible.

And the problem that we're solving is massive and very tangible, which is, I would say, not always the case with healthcare startups.

Yeah.

And in a sense, I guess a combination of both is that COVID made it really tough to be selling to health systems because all of their focus went away from innovation, went away from all of their areas aside for COVID.

For me, I was very passionate about the problem we were solving and didn't really want to pivot the business just to make money.

That wasn't what was so interesting to me at the time.

Yeah, so let's say you're a 65-year-old patient who is managed by a complex care team.

So you are in the hospital, you're discharged, you go home, you're on 10 different medications.

Your care manager would essentially either do this in the background or reach out to you, review your medications with MDI software, see what risks are posed to you because of your medication regimen.